GSK strikes £1.1bn deal for asthma drugmaker

GSK has bought a drug to treat severe asthma in a $1.4bn (£1.1bn) deal.

Related Keywords

China ,Khurem Farooq ,Aiolos Bio ,Tony Wood ,Astrazeneca ,Jiangsu Hengrui Pharmaceuticals ,Atlas Venture ,Bain Capital Life Sciences ,Bain Capital Life ,Medical Trials ,Respiratory Medicines ,Adult Patients ,Asthma ,